Cardiac Magnetic Resonance-assessed Subclinical Cardiac Dysfunction During 2 Years After Breast Cancer Irradiation: The Medirad-early Heart Study

• Jérôme Lamy, PhD,
• Daan Spoor, MSc,
• Johannes Langendijk, MD, PhD,
• Rozemarijn Vliegenhart, MD, PhD,
• Arantxa Eraso, MD, PhD,
• Susana Constantino, PhD,
• Manuela Fiuza, MD, PhD,
• Nadjia Kachenoura, PhD,
• Anne Crijns, MD, PhD,
• Elie Mousseaux, MD, PhD

Affiliations

Jérôme Lamy, PhD

Université Paris Cité, INSERM, PARCC, APHP, Hôpital Européen Georges Pompidou

Daan Spoor, MSc

Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen

Johannes Langendijk, MD, PhD

Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen

Rozemarijn Vliegenhart, MD, PhD

Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen

Arantxa Eraso, MD, PhD

Department of Radiation Oncology, Institut Català d'Oncologia

Susana Constantino, PhD

Laboratory of Angiogenesis, Centro Cardiovascular da Universidade de Lisboa, Lisbon

Manuela Fiuza, MD, PhD

Laboratory of Angiogenesis, Centro Cardiovascular da Universidade de Lisboa, Lisbon

Nadjia Kachenoura, PhD

Laboratoire d'Imagerie Biomédicale, Sorbonne Université

Anne Crijns, MD, PhD

Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen

Elie Mousseaux, MD, PhD

Université Paris Cité, INSERM, PARCC, APHP, Hôpital Européen Georges Pompidou